Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine in various areas such as biomarker assays, isobaric and isotopic reagents, biomarker services and proprietary biomarkers. The company specializes in providing proteomics and peptidomics services and applications, and mass spectrometry protein analysis capability. It offers PS Biomarker Services under which it provides integrated proteomic services for the discovery, validation and measurement in clinical trials and in vitro diagnostics of biomarkers. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer’s, Huntington’s, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in Cobham, the UK. Proteome Sciences Plc (PRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings,... Research Beam Model: Research Beam Product ID: 1995118 250 USD New
Proteome Sciences Plc (PRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Proteome Sciences Plc (PRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : August   2017
  • Pages : 50
  • Publisher : GlobalData
 
 
 
Summary

Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine in various areas such as biomarker assays, isobaric and isotopic reagents, biomarker services and proprietary biomarkers. The company specializes in providing proteomics and peptidomics services and applications, and mass spectrometry protein analysis capability. It offers PS Biomarker Services under which it provides integrated proteomic services for the discovery, validation and measurement in clinical trials and in vitro diagnostics of biomarkers. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer’s, Huntington’s, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in Cobham, the UK.

Proteome Sciences Plc (PRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Proteome Sciences Plc, Medical Devices Deals, 2011 to YTD 2017 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Equity Offering 14
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 18
Proteome Sciences Plc - Key Competitors 19
Proteome Sciences Plc - Key Employees 20
Proteome Sciences Plc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 22
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 23
Sep 15, 2016: Proteome Sciences: Interim Results 37
May 18, 2016: Proteome Sciences: Preliminary Results for Year Ended 31st December, 2015 38
Corporate Communications 41
Aug 01, 2017: Proteome Sciences: Directorate changes 41
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 42
Jun 01, 2016: Proteome Sciences Announces CEO Appointment 43
May 18, 2016: Proteome Sciences: CEO Appointment 44
Product News 45
Apr 05, 2016: Proteome Sciences: Deep Protein Profiling Key To Improving Cancer Treatment
Other Significant Developments 46
Jun 12, 2017: Proteome Sciences: New Registered Address 46
Jul 28, 2016: Proteome Sciences: Trading Updateand Notice of Results 47
Mar 09, 2016: Proteome Sciences: Trading update 48
Feb 29, 2016: Proteome Sciences: Trading Update 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Proteome Sciences Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Proteome Sciences Plc, Medical Devices Deals, 2011 to YTD 2017 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 18
Proteome Sciences Plc, Key Competitors 19
Proteome Sciences Plc, Key Employees 20
Proteome Sciences Plc, Subsidiaries 21
List of Figures
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Proteome Sciences Plc, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter